Bank of America’s Soleno Therapeutics SLNO Stock Holding History

Bank of America’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,000	Closed	-$2.5M	–	8642
2025 Q1	$2.5M	Buy	+35,000	New	+$1.7M	﹤0.01%	4480

Bank of America's SLNO Position: Q2 2026 in Review

Bank of America sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 439,902 shares — an estimated $14.7M sold.

Bank of America first reported a position in SLNO in Q3 2016 and held it in 27 quarters. The position peaked at $30.7M in Q1 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Bank of America reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Bank of America sold 439,902 Soleno Therapeutics shares in Q2 2026, an estimated $14.7M.
Bank of America first reported a position in Soleno Therapeutics in Q3 2016 and held it in 27 quarters.
Bank of America's Soleno Therapeutics position peaked at $30.7M in Q1 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.